[vc_row][vc_column][vc_column_text]

Autism Spectrum Disorders in Europe (ASDEU)

Understanding about autism will get a boost as universities, charities and expert institutions from 14 European countries come together in a major new programme. Autism Spectrum Disorders in Europe (ASDEU) has been funded by the European Commission to research autism diagnosis, prevalence and interventions and to improve care and support for people with autism.

Autism Spectrum Disorders in Europe (ASDEU) is a three-year programme run by a consortium of 20 groups from 14 countries. ASDEU has received 2.1 million euros from the Directorate-General of Health and Consumers of the European Commission (DG-SANCO) to increase understanding of and improve responses to autism. It will: study the prevalence of autism in 12 countries in the European Union; analyse the economic and social costs of autism; review existing arrangements and develop proposals for early detection programmes; train professionals; validate biomarkers for the disorder; and improve understanding of diagnosis, comorbidity, and effective care and support for adults and senior citizens with autism.

In the field of public health, ASDEU will also collaborate with European Autism Interventions – A Multicentre Study for Developing New Medications (EU-AIMS) http://www.eu-aims.eu to improve quality of life and prognosis for people with autism.

[/vc_column_text][vc_separator][/vc_column][/vc_row][vc_row][vc_column][vc_single_image image=”35″ img_size=”full” alignment=”center” style=”vc_box_rounded”][vc_separator][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text]

The ASDEU consortium associated partners are:

  • Programme lead: Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III (ISCIII), Spain
  • Medical University of Vienna, Austria
  • Autism Europe, Belgium
  • Ghent University, Belgium
  • Bulgarian Association for Promotion of Education and Science, Bulgaria
  • Aarhus University, Denmark
  • University of Oulu, Finland
  • University Toulouse 2 Jean Jaurès UT2J, France
  • The State Diagnostic and Counselling Centre, Iceland
  • The IRCCS Stella Maris Foundation, Italy
  • Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal
  • University of Warsaw, Poland
  • Dublin City University, Republic of Ireland
  • Victor Babes National Institute of Pathology, Romania
  • Fundación Canaria para el Avance de la Biomedicina y la Biotecnología, Canary Islands,  Spain
  • Fundación Española para la Cooperación Internacional, Salud y Política Social, Spain
  • Universidad de Salamanca, Spain
  • London School of Economics and Political Science, United Kingdom
  • King’s College London, United Kingdom
  • National Autistic Society, United Kingdom

[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_column_text]

Collaborating Partners:

  • Istituto Superiore di Sanità, Italy
  • Policlínica Gipuzkoa, Spain

 

The project lead, Manuel Posada, Director of the Rare Diseases Research Institute – ISCIII, Spain, will be supported in his management role by the ISCIII and the Spanish Foundation for Health and International Cooperation. Joaquin Fuentes, from Policlínica Gipuzkoa in Donostia / San Sebastián, Spain, and European Society for Child and Adolescent Psychiatry (ESCAP) Autism Field Advisor, will act as Scientific Advisor to the ASDEU project leader.

[/vc_column_text][vc_separator][vc_single_image image=”42″ img_size=”medium” alignment=”center”][/vc_column][/vc_row]